Exercise and Diet Intervention Attenuated Inflammation Through ASC Gene and Inflammatory Markers in Obese Adults
INDIEX
Exercise Program and Diet Intervention Attenuated Inflammation Through Down-regulation of ASC Gene and Inflammatory Markers in Obese Adults
1 other identifier
interventional
37
1 country
1
Brief Summary
Background: Obesity is one of the most important health problems worldwide, several factors related to lifestyle as physical inactivity and unbalanced diets increase their development. This condition is characterized by low-chronic inflammation by excess of adipose tissue. The apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) protein is part of NLRP3 inflammasome, a complex related to inflammation and metabolic alterations. Purpose: The aim of this study was to evaluate the effect of physical exercise program on ASC gene expression and inflammatory markers in obese adults. Methods: 37 obese individuals were randomized to exercise-diet group or diet-group during a 4-month follow-up period. The dietary evaluation was analyzed by Nutritionist Pro software. Body composition was evaluated by bioimpedance (InBody 370). All biochemical determinations were analyzed by dry chemistry (Vitros 350). ASC messenger ribonucleic acid (mRNA) expression was performed by real-time polymerase chain reaction (PCR) using Taqman probes and by the 2-ΔΔcq quantification method. Cytokine levels was performed using the Bio-PlexPro™ HumanTh17Cytokine Assays (MagPix) panel. Statistical analysis was performed with Statistical Package for the Social Sciences (SPSS) v.22 software.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2019
CompletedFirst Submitted
Initial submission to the registry
March 15, 2020
CompletedFirst Posted
Study publicly available on registry
March 19, 2020
CompletedMarch 19, 2020
March 1, 2020
1 year
March 15, 2020
March 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in ASC mRNA Expression
The polymorphonuclear cells were separated using Dextran treatment from peripheral blood samples. Subsequently, TRIzol® reagent was using according to the manufacturer´s instructions. The complementary DNA (cDNA) synthesis was performed according to standard techniques. Quantitative real-time PCR was performed using TaqMan® probes in Light Cycler 96 equipment considering standards PCR conditions to analyze ASC mRNA relative expression by 2-ΔΔcq method. The amplification reactions were performed in duplicate using β-Actin gene as constitutive gene to normalized the samples.
Mean change from baseline (0 Month) to end of treatment at 4th Month.
Change in Pro-inflammatory and Anti-inflammatory Cytokines
The pro-inflammatory and anti-inflammatory cytokines quantification were using Bio-Plex Pro™ Human cytokine Standard 17-Plex, Group I kit following the supplier's instructions, and the read was immediately by MAGPIX™ analyzer.
Mean change from baseline (0 Month) to end of treatment at 4th Month.
Change in Astrand-rhyming Submaximal Test
The Astrand-rhyming submaximal test was performed as described by Astrand.
Mean change from baseline (0 Month) to end of treatment at 4th Month.
Secondary Outcomes (12)
Changes in Height
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month. 1st month, 2nd month, 3th month and the 4th month.
Changes in Weight
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
Changes in Body Mass Index (BMI)
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
Changes in Waist Circumference
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
Changes in Fat Mass
At the baseline (0 Month) and 1st month, 2nd month, 3th month and the 4th month.
- +7 more secondary outcomes
Study Arms (2)
Exercise-Diet Group
EXPERIMENTALThe participants receive a personal exercise program according to Astrand-rhyming test baseline results, and a hypo-caloric diet intervention
Diet Group
ACTIVE COMPARATORThe participants no receive a personal exercise program, only the hypo-caloric diet
Interventions
The participants who performed exercise-diet intervention performed an Astrand-rhyming test before and after the exercise program intervention. Participants followed a progressive exercise-program during four months according to initial physical fitness. The main exercises consisted of improving aerobic, speed and resistance performance. During all single sessions, breathlessness and fatigue were measured using 0 to10 Borg scale. A personal trainer certified by American College of Sports Medicine (ACSM) supervised three sessions per week, the other two unsupervised training days the subjects were given the detailed training program to do in house/park. And also, this group received a diet intervention that consisted of a 20 percentage reduction of total energy expenditure estimated by the Mifflin formula with a nutrients distribution as follows: 50% carbohydrates, 30% lipids, and 20% proteins.
This group received a diet intervention that consisted of a 20 percentage reduction of total energy expenditure estimated by the Mifflin formula with a nutrients distribution as follows: 50% carbohydrates, 30% lipids, and 20% proteins.
Eligibility Criteria
You may qualify if:
- BMI greater than 30 kg/m\^2
- Sedentary individuals
- Both genres
- Waist circumference greater than 80 centimeters in women and greater than 90 centimeters in men
You may not qualify if:
- Pregnant or breastfeeding women
- Diagnosis of any metabolic disease or cancer
- Alcohol or tobacco consumption
- Muscle or joint injury
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erika Martínez-López
Guadalajara, Jalisco, 44340, Mexico
Related Publications (7)
ASTRAND PO, RYHMING I. A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during sub-maximal work. J Appl Physiol. 1954 Sep;7(2):218-21. doi: 10.1152/jappl.1954.7.2.218. No abstract available.
PMID: 13211501RESULTLin CH, Chiang SL, Tzeng WC, Chiang LC. Systematic review of impact of lifestyle-modification programs on metabolic risks and patient-reported outcomes in adults with metabolic syndrome. Worldviews Evid Based Nurs. 2014 Dec;11(6):361-8. doi: 10.1111/wvn.12069.
PMID: 25488565RESULTOzaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J Inflamm Res. 2015 Jan 16;8:15-27. doi: 10.2147/JIR.S51250. eCollection 2015.
PMID: 25653548RESULTRoss R, Hudson R, Stotz PJ, Lam M. Effects of exercise amount and intensity on abdominal obesity and glucose tolerance in obese adults: a randomized trial. Ann Intern Med. 2015 Mar 3;162(5):325-34. doi: 10.7326/M14-1189.
PMID: 25732273RESULTTaniguchi S, Sagara J. Regulatory molecules involved in inflammasome formation with special reference to a key mediator protein, ASC. Semin Immunopathol. 2007 Sep;29(3):231-8. doi: 10.1007/s00281-007-0082-3. Epub 2007 Sep 6.
PMID: 17805543RESULTYou T, Arsenis NC, Disanzo BL, Lamonte MJ. Effects of exercise training on chronic inflammation in obesity : current evidence and potential mechanisms. Sports Med. 2013 Apr;43(4):243-56. doi: 10.1007/s40279-013-0023-3.
PMID: 23494259RESULTBarron-Cabrera E, Gonzalez-Becerra K, Rosales-Chavez G, Mora-Jimenez A, Hernandez-Canaveral I, Martinez-Lopez E. Low-grade chronic inflammation is attenuated by exercise training in obese adults through down-regulation of ASC gene in peripheral blood: a pilot study. Genes Nutr. 2020 Aug 27;15(1):15. doi: 10.1186/s12263-020-00674-0.
PMID: 32854610DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erika Martínez-López, PhD
University of Guadalajara
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Study director
Study Record Dates
First Submitted
March 15, 2020
First Posted
March 19, 2020
Study Start
February 10, 2018
Primary Completion
February 15, 2019
Study Completion
February 15, 2019
Last Updated
March 19, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share
The individual participant data will not be shared to protect and safeguard the confidentiality data of the participants.